What may be the markers of the male equivalent of polycystic ovary syndrome?

Physiological Research

Volumn 53, Issue 3, 2004, Pages 287-294

  Duşková, Michaela ^a   Cermakova I ^a   Hill, M ^a   Vankova M ^a   Samalikova P ^a   Starka L ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Insulin tolerance; Male phenotype of PCOS; Polycystic ovary syndrome; Premature androgenic alopecia; SHBG

Indexed keywords

ANDROSTANOLONE; ANDROSTENEDIONE; EPITESTOSTERONE; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; PRASTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROTROPIN;

ADULT; ALLELE; ALOPECIA; ARTICLE; AUTOSOMAL DISORDER; BODY MASS; CLINICAL ARTICLE; DISEASE MARKER; ENDOCRINE DISEASE; HAIR LOSS; HUMAN; INSULIN RESISTANCE; MALE; MALE TYPE ALOPECIA; METABOLIC DISORDER; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREVALENCE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ALOPECIA; BIOLOGICAL MARKERS; ENDOCRINE SYSTEM DISEASES; FEMALE; HORMONES; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MINISATELLITE REPEATS; POLYCYSTIC OVARY SYNDROME; PREVALENCE; SYNDROME;

EID: 2942726433     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ANDRES R: Testosterone and the metabolic syndrome. Aging Male 7: 47, 2004.
2. ASUNCION M, CALVO RM, SAN MILLAN JL, SANCHO J, AVILA S, ESCOBAR-MORREALE HF: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85: 2434-2438, 2000.
3. BÍLEK R, HAMPL R, PUTZ Z, STÁRKA L: Radioimmunoassay of epitestosterone: methodology, thermodynamic aspects and applications. J Steroid Biochem 28: 723-729, 1987.
4. CAREY AH, CHAN KL, SHORT F, WHITE D, WILLIAMSON R, FRANKS S: Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol 38: 653-658, 1993.
5. CHOI MH, YOO YS, CHUNG BC: Biochemical roles of testosterone and epitestosterone to 5α-reductase as indicators of male-pattern baldness. J Invest Dermatol 116: 57-61, 2001.
6. DENMARK-WAHNEFRIED W, SCHILDKRAUT JM, THOMPSON D, LESKO SM, MCINTYRE L, SCHWINGL P, PAULSON DF, ROBERTSON CN, ANDERSON EE, WALTHER PJ: Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 9: 325-328, 2000.
7. DUNAIF A, THOMAS A: Current concepts in the polycystic ovary syndrome. Annu Rev Med 52: 401-419, 2001.
8. ELLIS JA, HARRAP SB: The genetic of androgenetic alopecia. Clin Dermatol 19: 149-154, 2001.
9. FERRIMAN D, PURDIE AW: The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol (Oxf) 11: 291-300, 1979.
10. FORD ES, FREEDMAN DS, BYERS T: Baldness and ischemic heart disease in a national sample of men. Am J Epidemiol 143: 651-657, 1996.
11. GILES GG, SEVERI G, SINCLAIR R, ENGLISH DR, McCREDIE MR, JOHNSON W, BOYLE P, HOPPER JL: Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev 11: 549-553, 2002.
12. GOVIND A, OBHRAI MS, CLAYTON RN: Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 84: 43-53, 1999.
13. HAMPL R, PUTZ Z, STÁRKA L: Radioimmmunological determination of dihydrotestosterone and its value for laboratory diagnostics. Biochemia Clin Bohemoslov 19: 157-163, 1990.
14. HAWK E, BRESLOW RA, GRAUBARD BI: Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 9: 523-527, 2000.
15. HERRERA CR, D'AGOSTINO RB, GERSTMAN BB, BOSCO LA, BELANGER AJ: Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol 142: 828-833, 1995.
16. LEGRO RS: Is there a male phenotype in polycystic ovary syndrome families? J Pediatr Endocrinol Metab 13: 1307-1309, 2000.
17. LESKO SM, ROSENBERG L, SHAPIRO S: A case-control study of baldness in relation to myocardial infarction in men. J Am Med Assoc 269: 998-1003, 1993.
18. LIVINGSTONE C, COLLISON M: Sex steroids and insulin resistance. Clin Sci 102: 151-166, 2002.
19. LOTUFO PA, CHAC C, AJANI UA, HENNEKENS CH, MANSON JE: Male pattern baldness and coronary heart disease. Arch Int Med 160: 165-171, 2000.
20. ROTTERDAM ESHRE/ASRM-SPOSORED PCOS CONSENSUS WORKSHOP GROUP: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19-25, 2004. Hum Reprod 19: 41-47, 2004.
21. ROTTERDAM ESHRE/ASRM-SPOSORED PCOS CONSENSUS WORKSHOP GROUP: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19-25, 2004. Hum Reprod 19: 41-47, 2004.
22. SINCLAIR RD, DAWBER RPR: Androgenetic alopecia in men and women. Clin Dermatol 19: 167-178, 2001.
23. STÁRKA L, HAMPL R, BIČÍKOVÁ M, JELÍNEK R, DOSKOČIL M: Observations on the biological activity of epitestosterone. Physiol Res 40: 317-326, 1991.
24. STÁRKA L, HILL M, POLÁČEK V: Hormonal profile in men with premature androgen alopecia. (in Czech) Sb Lék 101: 17-22, 2000.
25. STÁRKA L, ČERMÁKOVÁ I, DUŠKOVAÆ M, HILL M, POLÁČEK V: Hormonal profile of men with premature balding. Exp Clin Endocrinol Diabet 112: 24-28, 2004.
26. VAŇKOVÁ M, VRBíKOVÁ J, HILL M, CINEK O, BENDLOVÁ B. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Ann NY Acad Sci 967: 558-565, 2002.
27. XITA N, GEORGIOU I, TSATSOULIS A: The genetic basis of polycystic ovary syndrome. Eur J Endocrinol 147: 717-725, 2002.
28. YILDIZ BO, YARALI H, OGUZ H, BAYRAKTAR M: Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88: 2031-2036, 2003.
29. YOUNG RP, CRITCHLEY JA, ANDERSON PJ, LAU MS, LEE KK, CHAN JC: The short insulin tolerance test: feasibility study using venous sampling. Diabet Med 13: 429-433, 1996.